NCT05873608Recruiting
Communication Issues in Patient and Provider Discussions of Immunotherapy
Communication Issues in Patient/Provider Discussions of Immunotherapy
Source: ClinicalTrials.gov · Last updated 6 Apr 2026
Brief summary (registry, in English)
This trials studies communication issues in patient and provider discussions about immunotherapy. The goal of this study is to describe where patients have heard about immunotherapy, what the participants understand about it, how physicians and other healthcare workers describe immunotherapy, and how educational videos may support patient knowledge about immunotherapy.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 125 (estimated)
- First submitted
- 16 May 2023
- Start date
- 6 Oct 2016
- Primary completion date
- 17 Sept 2027
- Lead sponsor
- Emory University
- Diseases
- Childhood cancers
- NCT number
- NCT05873608
What you commit to
- Study type: Interventional
- Planned participants: 125
- From 6 Oct 2016 to the primary completion date, 17 Sept 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- AIMS 1-3: All patients and providers who may have a discussion about immunotherapy at the Winship Cancer Institute
- AIM 4: Any cancer patient
Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Emory University Hospital/Winship Cancer Institute Coordinator of this site? Confirm its status | Atlanta | United States | Recruiting |
| Atlanta VA Medical Center Coordinator of this site? Confirm its status | Decatur | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.